How a $50B Investment Firm Automated Their Entire Research Pipeline With Claude

The investment firm was facing a critical scaling problem. Their research operation-market analysis, investment thesis development, due diligence, and deal flow discovery-was bottlenecked by a single senior analyst. The firm leadership decided to hire a research director to lead the operation. The cost: $500,000 to $1,000,000 per year. But before they pulled the trigger on that hire, they realized the manual research workflow was unsustainable. A typical research request took 5 days to complete. Market moves faster than that. Investment opportunities get missed. The team was spending time on research execution when they should have been focusing on strategy and decision-making. They had a team working under this person, but even with multiple analysts, the process was slow, siloed, and dependent on one person's expertise and availability. They needed a better way.

The firm deployed an AI employee powered by OpenClaw and Claude Opus 4.6. This wasn't just a research tool-it became their research director. The setup was deceptively simple: integrate the AI agent with the firm's proprietary investment data, Bloomberg feeds, and market research APIs. Then plug it into the daily workflow. Now, instead of assigning research to a person, the firm leader tells Claude: "Research XYZ opportunity. Cross-reference it against our portfolio. Flag if you see acquisition potential." The agent handles everything. It gathers market data, analyzes the opportunity against the firm's criteria and existing investments, synthesizes findings, and delivers a comprehensive research brief-complete with financial models, competitive analysis, risk assessment, and deal flow recommendations. The firm now runs 10+ research queries every single day through the Claude-powered agent. Each one comes back with the depth and accuracy that used to require days of manual work. The research is accurate because it's plugged directly into the firm's real data-not generic market analysis, but analysis specific to their portfolio, their investment thesis, and their deal pipeline.